Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

Caregivers of individuals diagnosed with acute leukemia face a difficult balancing act: meeting the urgent demands of cancer ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute have developed a cell therapy for a type of leukemia which currently has very few ...

Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.

Acute promyelocytic leukaemia (APL) represents a unique and once highly fatal subtype of acute myeloid leukaemia that is now considered among the most curable forms of haematological malignancies.

The Josep Carreras Institute becomes part of the Cancer Proteome Project, an international initiative for the study of malignant tumors The Spanish Minister of Science and Innovation, Diana Morant, ...

A common ingredient in some foods and drinks has been linked to faster progression of blood cancers. Taurine — a non-essential amino acid that also occurs naturally in the bone marrow, brain, heart ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Amgen acquires Dark Blue Therapeutics for up to $840 million, adding early-stage leukemia drug research and strengthening its oncology discovery pipeline.

CURE sat down with Dr. Kerry A. Rogers for an interview at the Hairy Cell Leukemia Foundation 2025 Conference, hosted in Bologna, Italy. We sat down with Dr. Kerry A. Rogers for an interview at the ...

Survival has improved greatly in children with acute lymphocytic leukemia (ALL). But a certain form of ALL that occurs mostly in babies is still very lethal, with a survival rate below 50 percent: ...